Covidien boosts endoscopy offering with New Wave, while recall hits sales
This article was originally published in Clinica
Covidien has reportedly paid $100m to acquire New Wave Surgical, a developer of laparoendoscopic surgical devices. The deal was announced on New Wave’s website on 28 March but was only widely reported last week, with the $100m fee unconfirmed but cited by several news outlets. Pompano Beach, Florida-based New Wave has developed a device called D-Help that keeps laparoscopic lenses clean and “defogged” during surgery. The product received US FDA 510(k) clearance in 2006, and was used in its millionth procedure in February. D-Help will be sold by Covidien as the Clearify visualization system – but apart from that, New Wave says existing customers will see little impact. But Covidien’s marketing reach should boost uptake of the device.